Search Results
Search results for "GPCR Drug Design"
Results found for "GPCR Drug Design"
- The Role of Quantitative Sciences in GPCRs with Dr. Nagarajan Vaidehi | Dr. GPCR Ecosystem
She has advanced the use of computational methods to meet the challenges of designing therapeutics with molecular dynamics simulation methods with emphasis on application to G-protein coupled receptors and drug design." GPCR Unlock the Full Dr. GPCR Podcast? Leave a Review.
- Join the Dr. GPCR Affiliate Program - Empower the GPCR Community with Dr. GPCR Ecosystem Services
GPCR Affiliate Program and earn commissions by helping connect the global GPCR community. Share our ecosystem, courses, and events to advance drug discovery together. Dr. GPCR community. The Ecosystem is designed for all GPCR professionals to have an affordable and highly effective way to GPCR Ecosystem?
- Annette Gilchrist: Native Cell Systems, Biased Agonism, and the Pharmacogenomics Gap | Dr. GPCR Ecosystem
agonism - a first-in-kind finding at wild-type FFA2 and its implications for biased ligand campaign design unexplored opportunity in existing drug pipelines Antibody therapeutics for GPCRs - the pipeline case The aha moment was not the result itself but recognizing what it meant for how you could design the campaign Almost no company with an approved GPCR-targeting drug has gone back to look at what common receptor It was not the experiment she had designed.
- A Brief History of allosteric modulation with Dr. Arthur Christopoulos | Dr. GPCR Ecosystem
His research focuses on novel paradigms of drug action at GPCRs, particularly allosteric modulation and the understanding and application of allosteric modulation. - Arthur will work on designing ligands design principles. GPCR Learning Ecosystem âś” Full Masterclass library âś” Terry's Pharmacology Corner âś” Advanced GPCR courses GPCR Podcast? Leave a Review.
- Brian Arey: Discovering Signaling Bias at the FSH Receptor | Dr. GPCR Ecosystem
pharmacology and drug design. Drug discovery needs modulators more than it needs hammers Arey's philosophy of drug discovery is grounded for a therapeutic strategy built around modulators that can be combined, rather than single agents designed He continues to pioneer in drug discovery studying GPCRs and other target classes. GPCR Podcast? Leave a Review.
- Leadership, Impact, and GPCR Signaling with Dr. Michelle Halls | Dr. GPCR Ecosystem
Michelle Halls shares how dissecting the spatial organization of GPCR signaling opens new doors in drug the Guest Michelle Halls is an Associate Professor at Monash University and Deputy Theme Leader of Drug GPCR Premium . GPCR Learning Ecosystem âś” Full Masterclass library âś” Terry's Pharmacology Corner âś” Advanced GPCR courses GPCR Podcast? Leave a Review.
- Arun Shukla: How Two Arrestins Regulate 800 GPCRs | Dr. GPCR Ecosystem
structural stabilization and live-cell conformational reporting The limits and promise of biased agonism in drug effect, physiological examples of the beta-arrestin-biased receptors pharmacologists have been trying to design The neat bifurcation between G-protein and beta-arrestin signaling that drove early opioid receptor drug design has not held up cleanly in subsequent studies. Shukla's lab designed antibody fragments to stabilize GPCR–beta-arrestin complexes for structural studies
- Visualizing GLP-1 & GIP Receptors in Islets and Brain | Dr. GPCR Ecosystem
drug discovery . circuits — insights that inform next-generation functional assay development and translational therapeutic design Why this matters How receptor distribution in islets and brain circuits shapes incretin hormone drug collaborative chemistry enabled in designing receptor-targeted fluorescent ligands The moment when structural GPCR Podcast? Leave a Review.
- Chris Tate: Thermostabilizing GPCRs for Structural Biology | Dr. GPCR Ecosystem
architecture - what a dimer with no prior blueprint looks like What remains unsolved: why drug discovery Drug discovery's real bottleneck is not structural Tate is direct about where the field now stands: accumulating GPCR structures is no longer the limiting step in drug discovery. GPCR Ecosystem Unlock the Full Dr. GPCR Podcast? Leave a Review.
- Dr. Aurélien Rizk | Dr. GPCR Ecosystem
Aurélien Rizk is a scientist and entrepreneur in drug discovery. Before focusing on the development of innovative mathematical modeling and simulation methods for drug Interdisciplinary Teamwork and Drug Development Yamina Berchiche and Aurelien Rizk emphasized the significance of interdisciplinary teamwork in drug and technology development, noting the challenges of communication Aurelien Rizk confirmed his attendance at the upcoming GPCR-Targeted Drug Discovery Summit in Boston.
- Smells Like GPCR Spirit: Cracking Olfactory Codes with Alessandro Nicoli | Dr. GPCR Ecosystem
“I think I don’t have a linear trajectory… the beauty of seeing molecule design and reactions—thinking Alessandro Nicoli He studied pharmaceutical chemistry in Padua, where his fascination with molecular design “I got to know computational chemistry through a project on BCL2 proteins and drug discovery… I was in close to experimental structures, provided a powerful starting point for docking, dynamics, and ligand design—especially drug discovery pipelines.
- Xylazine, Fentanyl, and the Fight for Breath with Catherine Demery | Dr. GPCR Ecosystem
From her early doubts to designing preclinical models of fentanyl and xylazine overdose, she reflects pharmacologist—led her to investigate how these drugs shut down breathing in different ways. Who Should Listen This episode is especially relevant for: GPCR drug discovery scientists Respiratory GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.
- Dr. Katarina Nemec | Dr. GPCR Ecosystem
engaged in researching molecular mechanisms that govern human (patho-)physiology and their interplay with drugs I aim to discover new therapeutic approaches, and druggable molecules or refine canonical drug targets to create drugs with fewer adverse effects. GPCR Unlock the Full Dr. GPCR Podcast? Leave a Review.
- Dr. GPCR Univeristy for Developing Countries | Dr. GPCR Ecosystem
Advancing GPCR science, together—everywhere. To support the global GPCR community, Dr. drug discovery. GPCR Premium including but not limited to: Dr. GPCR Masterclass Live events Dr. GPCR Masterclass On-Demand library Dr.
- Chemical Probes for GPCR Imaging and Internalization with Dr. Johannes Broichhagen | Dr. GPCR Ecosystem
GPCR Podcast, chemical biologist Dr. drug discovery . He explains what chemical design can solve that antibodies can’t, how to validate functional assay systems Why this matters How a chemist with zero biology training became a leader in GPCR probe design. GPCR Podcast? Leave a Review.
- Michel Bouvier: BRET, Biased Agonism, and the Tools That Changed GPCR Pharmacology | Dr. GPCR Ecosystem
from the endoplasmic reticulum, to the experimental frameworks that made biased agonism a credible drug mutants, and biosensor platforms that helped establish functional selectivity and biased agonism as drug to our understanding of this major class of drug targets. GPCR Ecosystem Unlock the Full Dr. GPCR Podcast? Leave a Review.
- Univeristy Lecturers Details | Dr. GPCR Ecosystem
Learn about course content, instructors, and how to advance your expertise in drug discovery. GPCR University Dr. Our flexible course formats are designed to fit your time, depth, and teaching goals — whether you’re GPCR University Instructor and help move GPCR science forward. Aside from his vast experience in drug development, not to mention his extensive publication record,
- Dr. Jean Martin Beaulieu | Dr. GPCR Ecosystem
target for drug development. and drug development technology. GPCR Ecosystem Unlock the Full Dr. GPCR Learning Ecosystem âś” Full Masterclass library âś” Terry's Pharmacology Corner âś” Advanced GPCR courses GPCR Podcast? Leave a Review.
- Paul Insel: Rethinking COVID-19 Pathobiology Through GPCR Signaling | Dr. GPCR Ecosystem
pneumocytes, beta-2 receptors, and the asthma parallel The ethics of acting on conviction — off-label drug gas pedals and brakes" frame — a lens that has quietly shaped how he reads both disease mechanism and drug GPCR Ecosystem Unlock the Full Dr. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.
- Dr. JoAnn Trejo | Dr. GPCR Ecosystem
biology and for the identification of drug targets and future drug development. which has important functions in hemostasis, thrombosis, inflammation, and cancer and is an important drug GPCR Ecosystem Unlock the Full Dr. GPCR Learning Ecosystem âś” Full Masterclass library âś” Terry's Pharmacology Corner âś” Advanced GPCR courses GPCR Podcast? Leave a Review.
- Jane Lamerdin and Gaurav Agrawal: Building GPCR Assays That Reflect Real Biology | Dr. GPCR Ecosystem
Obesity and GLP-1 biology changed that, and the largest target class is once again at the front of drug brings more than twenty years of industry experience across diverse cell-based assays, supporting client drug to the front of drug discovery De-orphanizing GPCRs, including receptors stuck in the endoplasmic reticulum GPCRs never left; the attention did. GPCR Podcast? Leave a Review.
- Donate to Dr GPCR — Support the GPCR Community & University
Join us in strengthening the global GPCR community. Dr GPCR is a 501(c)(3) non-profit. 501(c)(3) Non-Profit Help Us Build a Global Home for GPCR Science GPCR Ecosystem open, reliable, and thriving. GPCR University Premium to a colleague, mentee, or even yourself — the gift of cutting-edge GPCR education more effective drugs for everyone.
- GPCRs and the Science Behind Pain and Recovery with Dr. Alex Serafini | Dr. GPCR Ecosystem
targets — a top-down rethink for drug discovery. << Back to podcast list Strategic Partner(s) GPCRs “We’re using outdated drugs. There are more elegant GPCR targets waiting to be explored.” He’s fascinated by transgenerational epigenetics — how parental pain, diet, or drug exposure can leave GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.
- Dr. Juan José Fung | Dr. GPCR Ecosystem
Juan José Fung is a Principal Scientist at GPCR Therapeutics, Inc , a drug discovery company focused spent significant time in the industry studying membrane proteins, antibodies, and HTS methods for drug Juan José Fung on the web LinkedIn GPCR Therapeutics Dr. GPCR Ecosystem Unlock the Full Dr. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.
- Kari Johnson: mGlu2, Addiction, and the Brain Circuits Alcohol Rewires | Dr. GPCR Ecosystem
researchers cannot determine why promising preclinical findings did not translate, cannot adjust future trial designs still good drug targets? GPCR Ecosystem Unlock the Full Dr. GPCR Learning Ecosystem âś” Full Masterclass library âś” Terry's Pharmacology Corner âś” Advanced GPCR courses GPCR Podcast? Leave a Review.
- Dr. Daniel Wacker | Dr. GPCR Ecosystem
and in vitro drug discovery. Icahn School of Medicine at Mount Sinai in NYC, where I have been working on structure-function and drug GPCR Ecosystem Unlock the Full Dr. GPCR Learning Ecosystem âś” Full Masterclass library âś” Terry's Pharmacology Corner âś” Advanced GPCR courses GPCR Podcast? Leave a Review.
- Dr. Terry Hebert: A Pharmacologist Thinking Through Lockdown | Dr. GPCR Ecosystem
Key Insights from the Conversation Challenge trials don't work without a reliable drug. Dr. design can responsibly change. 90 vaccine candidates is a number about effort, not probability. GPCR Ecosystem Unlock the Full Dr. GPCR Learning Ecosystem âś” Full Masterclass library âś” Terry's Pharmacology Corner âś” Advanced GPCR courses GPCR Podcast? Leave a Review.
- Dr. Josephine (Pina) Cardarelli | Dr. GPCR Ecosystem
Cardarelli is a drug development leader with extensive experience driving drug discovery teams in bringing She has extensive experience working with Biologics, and Antibody Drug Conjugates as well as experience GPCR Ecosystem Unlock the Full Dr. GPCR Learning Ecosystem âś” Full Masterclass library âś” Terry's Pharmacology Corner âś” Advanced GPCR courses GPCR Podcast? Leave a Review.
- Amynah Pradhan: The Delta Opioid Receptor and the Migraine Paradox | Dr. GPCR Ecosystem
Internalization is a design choice, not a side effect. it 09:27 What chronic dosing does to the receptor — tolerance, internalization, downregulation 14:17 Designing GPCR Ecosystem Unlock the Full Dr. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.
- GPCR location matters with Dr. Gabriele Kockelkoren | Dr. GPCR Ecosystem
<< Back to podcast list Strategic Partner(s) GPCR location matters with Dr. In my PhD, I studied the nanoscale spatial organization of G protein-coupled receptors (GPCRs) at the revealed heterogeneous spatial patterns of receptor density and activation, that are modulated in a drug-dependent GPCR Learning Ecosystem âś” Full Masterclass library âś” Terry's Pharmacology Corner âś” Advanced GPCR courses GPCR Podcast? Leave a Review.



























